Drug Type Synthetic peptide vaccine, Therapeutic vaccine |
Synonyms- |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | US | 01 Sep 2024 | |
HER2 Positive Breast Cancer | Phase 1 | US | 01 Sep 2024 | |
HER2-positive gastric cancer | Phase 1 | US | 01 Sep 2024 | |
Metastatic breast cancer | Phase 1 | US | 01 Sep 2024 | |
Metastatic Digestive System Carcinoma | Phase 1 | US | 01 Sep 2024 | |
Metastatic Solid Tumor | Phase 1 | US | 01 Sep 2024 |